Insiders Incyte Corporation

Equities

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 22/04/2026 am IST			5-day change	1st Jan Change
96.22 ^USD	-0.72%		-1.50%	-2.58%

22/04	Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing	MT
21/04	Incyte Highlights New Phase 3 Tafasitamab Data At the 2026 American Society of Clinical Oncology Annual Meeting	CI

Insiders

22/04	Incyte Insider Sold Shares Worth $1,801,366, According to a Recent SEC Filing	MT
08/04	Palvella Therapeutics, Inc. Appoints Kent Taylor as Senior Vice President of Sales	CI
31/03	Incyte Corporation Announces Resignation of Susanne Schaffert from the Board of Directors, Effective April 15, 2026	CI
26/03	Geron Corporation Announces the Appointment of Patricia S. Andrews and Constantine Chinoporos to Board of Directors	CI
25/03	Incyte Corporation Announces Executive Changes	CI
09/01	Incyte Insider Sold Shares Worth $1,184,064, According to a Recent SEC Filing	MT
07/01	Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs	CI
13/12	Incyte Insider Sold Shares Worth $554,965, According to a Recent SEC Filing	MT
12/12	Incyte Corporation Announces Resignation of Hervé Hoppenot from Board of Directors, Effective December 12, 2025	CI
01/12	Incyte appoints Richard Hoffman as executive vice president and general counsel	RE
01/12	Incyte Corporation Announces Executive Changes	CI
08/11	Incyte Insider Sold Shares Worth $534,813, According to a Recent SEC Filing	MT
06/11	Incyte Insider Sold Shares Worth $289,017, According to a Recent SEC Filing	MT
07/25/07	Incyte Insider Sold Shares Worth $351,978, According to a Recent SEC Filing	MT
06/25/06	Maze Therapeutics Appoints Herve Hoppenot as Board Chairman	MT
04/25/04	Incyte appoints Thomas Tray as principal financial officer - SEC filing	RE
22/25/22	Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer, Effective September 22, 2025	CI
25/25/25	Incyte names Soni Basi as Executive Vice President and Chief Human Resources Officer	RE
25/25/25	Incyte Announces Executive Changes, Effective August 25, 2025	CI
07/25/07	Incyte Corp - CFO Christiana Stamoulis to step down September 16 - SEC filing	RE
06/25/06	Mallinckrodt plc Announces Board Changes, Effective September 22, 2025	CI
06/25/06	Incyte Corporation Announces Departure of Christiana Stamoulis as Executive Vice President, Effective September 16, 2025	CI
06/25/06	Incyte Corporation Announces Departure of Christiana Stamoulis as Chief Financial Officer, Effective September 16, 2025	CI
29/25/29	Incyte's new CEO outlines growth plan as Jakafi patent cliff nears	RE
24/25/24	Incyte Insider Sold Shares Worth $251,786, According to a Recent SEC Filing	MT